Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (127)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ali, R. R.
Right arrow Articles by Bhattacharya, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ali, R. R.
Right arrow Articles by Bhattacharya, S. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics Pages 591-594

Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Introduction
Results
Discussion
Materials And Methods
   Preparation and titration of viruses
   Subretinal injections
   X-gal reaction
   Histology
Acknowledgements
References


Gene transfer into the mouse retina mediated by an adeno-associated viral vector

Gene transfer into the mouse retina mediated by an adeno-associated viral vector Robin R. Ali*, Martin B. Reichel, Adrian J. Thrasher1, Roland J. Levinsky1, Christine Kinnon1, Naheed Kanuga, David M. Hunt and Shomi S. Bhattacharya

Department of Molecular Genetics, Institute of Ophthalmology, University College London, Bath St., London EC1V 9EL, UK and 1Division of Cell and Molecular Biology, Institute of Child Health, University College London, Guilford St., London WC1N 1EH, UK

Received January 26, 1996; Revised and Accepted February 26, 1996

Gene transfer to photoreceptor cells may provide a means for arresting the retinal degeneration that is characteristic of many inherited causes of blindness, including retinitis pigmentosa (RP). However, transduction of photoreceptors has to date been inefficient, and further limited by toxicity and immune responses directed against vector-specific proteins. An alternative vector system based on adeno-associated virus (AAV) may obviate these problems, and may be useful for transduction of neuronal cells. In this study we have demonstrated successful transduction of all layers of the neuroretina as well as the retinal pigment epithelium (RPE) following subretinal injection of recombinant AAV particles encoding lac Z. Furthermore, the efficiency of transduction of photoreceptors is significantly higher than that achieved with an equivalent adenoviral vector. This is the first report showing that AAV is capable of transducing photoreceptor cells and supports the use of this vector system for gene therapy of retinal diseases such as RP.

INTRODUCTION

Inherited forms of retinal degeneration are relatively common causes of blindness in adult life (1 ). Of these, retinitis pigmentosa (RP) is the best characterised. Five different non-syndromic RP genes have been identified to date (2 -6 ) all of which are expressed exclusively in photoreceptor cells. However, photo- receptor cells and the retinal pigment epithelium (RPE) are in close proximity and are inter-dependent (the anatomy of the retina is shown in Fig. 1 a). Future research may reveal genes that are expressed in the RPE and which play a role in some forms of retinal degeneration [the Royal College of Surgeons' rat, for instance, has a single gene defect of the RPE which results in retinal degeneration (7 )]. Delivery of a normal gene or gene product to these cells may arrest the degenerative process and thus preserve vision.


Figure 1.(a) Histology of 4 week old BALB/c retina showing: ganglion cell layer (G); plexiform layer (PL); bipolar cell layer (B); photoreceptor cell layer (P) with inner (I) and outer segments (O); and RPE (R). Toluene blue semi-thin section (40* objective). (b) Schematic of the mouse eye. The route of subretinal injection is indicated.

The photoreceptor layer is most accessible to gene transfer by subretinal injection. However, experience obtained with adeno- virus (AV) based delivery systems suggests that transduction of photoreceptors is extremely inefficient in adult animals, and is further limited by toxicity at high multiplicities of infection (8 -11 ) and by immune responses directed against virally-encoded genes expressed from the vector backbone (manuscript in preparation). Vectors based on the non-pathogenic human parvovirus, adeno-associated virus (AAV), may offer considerable advantages with respect to toxicity and immunogenicity because they are deleted for all virally-encoded proteins. AAV has also been shown to infect neuronal cells in vivo (12 ). In this study, we have examined the potential for recombinant AAV encoding a reporter gene, lac Z, to transduce retinal cells.

RESULTS

In order to determine the efficiency of transduction of AAV in comparison to AV, and to exclude complications arising from the immunogenicity of the adenoviral backbone, or from the bacterial reporter gene lac Z, studies were conducted in immunodeficient nude mice. An adeno-associated viral vector with an internal CMV promoter-driven lac Z gene (AAV.CMVlacZ) at a titre of 107 infective units (iu) per ml was injected subretinally (Fig. 1 b) into adult nude mice resulting in detachments encompassing approximately 25% of each retina. The animals were sacrificed 28 days after the procedure. X-gal staining was observed only in the area corresponding to the retinal detachment around the site of injection. Within this area between 100 and 500 transduced photoreceptors were found either in small clusters or scattered as single cells (Fig. 2 a) in 50% of the eyes examined (n = 10). A total of 1100 positive photoreceptor cells were counted. In some cases we see staining throughout the photoreceptor: in the nucleus, cell body, inner and outer segments (Fig. 2 b). Observation of positive photoreceptors without staining of associated rod outer segments (ROS) may be a consequence of lower levels of [beta]-gal production in these particular cells, or a consequence of the angle of sectioning. Four weeks after injection of 2 [mu]l of AAV at a titre of 1 * 107 iu/ml, there was no evidence of direct toxicity. The proportion of transduced photoreceptor cells is significantly higher than with adenovirus containing a similar CMV promoter-driven lac Z reporter gene (AV.CMVlacZ). Only one positive photoreceptor cell was observed in all the eyes examined (n = 22) following subretinal injection of AV.CMVlacZ at a titre of 5 * 108 plaque forming units (pfu) per ml.

After injection with AAV.CMVlacZ, positive cells were also seen in other layers of the neuroretina: the ganglion cell layer (3rd neuron) as well as the bipolar cell layer, which includes the bipolar cells (2nd neuron) as well as Müller, amacrine and horizontal cells (Fig. 2 c). In addition to the transduced neuroretina, there were many positive RPE cells-up to 25% of the total-along with positive staining in the adjacent ROS layer (Fig. 2 d). A similar pattern of staining in the RPE and ROS layer is also observed after subretinal injection with AV.CMVlacZ (Fig. 2 e). The staining observed in the ROS layer may result from detached RPE microvilli or be due to secretion or diffusion of [beta]-gal from transduced RPE. This is supported by an additional experiment using an adenoviral vector containing a lac Z gene with a nuclear localisation signal. Following subretinal injection of AV.CMVlacZnuc (109 pfu/ml) we were unable to see any positive photoreceptor cell nuclei, even though the ROS layer was still stained (Fig. 2 f). However, positive staining was seen in the RPE cell nuclei. This indicates that only the RPE cells have been transduced.

DISCUSSION

In this study, we have demonstrated that AAV vectors mediate efficient transduction of retinal cells. Furthermore, transduction of photoreceptors is over two thousand-fold more efficient than that achieved with conventional adenovirus-based systems and is not associated with direct toxicity after one month. Therefore, adeno-associated viral vectors, although requiring further development, offer a promising way of targeting photoreceptor cells. Improvements in the production of AAV (allowing higher titres) along with alternative delivery methods that increase local concentrations are likely to raise substantially the proportion of transduced photoreceptor cells. However, it is not yet clear how many photoreceptors will have to be transduced in order to provide a significant restoration of function. For example, rescue of scattered photoreceptor cells may increase light perception, whilst in eyes with a fovea, focal targeting may enhance central vision. Transduction of the non-neuronal retinal pigment epithelium is particularly efficient and similar to that experienced using AV vectors. The intrinsic phagocytic activity of this layer may mediate efficient uptake of viral particles. Delivery of therapeutic genes to these cells may become useful for both inherited and acquired retinal pathology.


Figure 2.Blue X-gal staining indicates [beta]-gal activity in nude mouse retina 28 days after subretinal injection with 2 [mu]l of AAV.CMVlacZ (1 * 107 iu/ml), (a-d); 2 [mu]l of AV.CMVlacZ (5 * 108 pfu/ml), (e) and 2 [mu]l of AV.CMVlacZnuc (109 pfu/ml), (f). The 5 [mu]m paraffin sections were counterstained with nuclear fast red. (a) Arrows indicate scattered transduced photoreceptor cells (50* objective). (b) Transduced photoreceptors with staining throughout the whole cell, including outer segments (arrows) together with an adjacent section of transduced RPE (R) (100* objective). (c) Transduced cells in the ganglion (G) and bipolar (B) cell layers-orientation determined by large inner plexiform layer (PL) separating bipolar and ganglion cells (25* objective). (d) Transduced RPE with staining in the adjacent ROS layer; arrows indicate areas where, due to histological processing, the neuroretina has separated slightly from the RPE (50* objective). (e) Transduced RPE (R) with staining in the ROS layer (O). The retina has been displaced by histological processing (50* objective). (f) Positive RPE nuclei (R) and staining in the ROS layer (O) (25* objective).

a

b

c

d

e

f

Consistent with a previous study in which AAV particles were injected into rat brain (12 ), we have also seen a reduction of adeno-associated virus-mediated gene expression over time in immunocompetent animals (not shown). Although this could reflect repression of gene expression, a phenomenon which has been previously observed with CMV promoter elements in vivo, or the loss of the recombinant genome from infected cells, we have shown that expression persists for at least four weeks in immunodeficient nude mice. These observations point to an immune-mediated loss of cells, possibly directed against the bacterial reporter gene lac Z, although contamination of AAV stocks with residual wild-type helper adenovirus cannot be discounted (see Materials and Methods). This limitation should be overcome by the use of AAV vectors encoding endogenous genes, and by the development of more sophisticated methods for producing purified AAV stocks. Efficient and persistent gene transfer to all cell layers of the retina in vivo using AAV vectors may therefore provide a basis for gene therapy of many diseases of the eye, including degenerative diseases such as retinitis pigmentosa.

MATERIALS AND METHODS

Preparation and titration of viruses

AAV.CMVlacZ (pTRCMV[beta],N.M.) was packaged into infectious particles by co-transfection of a 293 cell line and infection with helper wild-type adenovirus type 5, as previously described (13 ). The AAV vector was purified and separated from adenovirus by sequential caesium chloride banding and finally concentrated by ultrafiltration in a Microcon® concentrator (Amicon Ltd., Stonehouse, Gloucestershire). Infectious titre of AAV preparations was determined by transduction of HeLa cells. AV stocks were prepared from infected 239 cell lysates, purified by sequential caesium chloride banding and titred by conventional plaque assay.

Subretinal injections

Mice were anaesthetised by ip injection of 0.2 ml Hypnorm (Janssen Pharmaceutical Ltd, Oxford), and Hypnovel (Roche, Welwyn Garden City) mixed 1:1:6 with distilled water. Following dilation with 1% tropicamide [1% Mydriacyl, Alcon Labs (UK) Ltd., Hemel Hempstead], the eyes were gently protruded using a rubber sleeve and subsequently covered with 2% hydroxypropylmethylcellulose in PBS and a cover slip. This allowed surgery to be performed under direct retinoscopy through an operating microscope. The tip of a 1.5 cm, 34-gauge hypodermic needle [Hamilton (GB) Ltd., Dundee] was brought into focus between the retina and RPE and approximately 2 [mu]l of PBS or viral suspension containing AAV.CMVlacZ, AV.CMVlacZ or AV.CMVlacZnuc was injected to produce a retinal detachment. All the mice [BALB/cOlaHsd-nu/nu (Harlan Olac Ltd., Bicester)] were injected on the same day by the same experienced operator and the procedure assessed for consistency by direct retinoscopy. The animals were 8 weeks old at the time of injection (+- 1 week).

X-gal reaction

Animals were killed by cervical dislocation and the enucleated eyes were prefixed by immersion in 10% buffered formalin for 45 min. The cornea and lens were removed and the eye cups rinsed in PBS and incubated overnight at room temperature with X-gal (5-bromo-4-chloro-3-indolyl-[beta]-D-galactopyranoside; Calbiochem, La Jolla Ca) in a solution containing 10 mM K3Fe(CN)6, 10 mM K4Fe(CN)6, 2 mM MgCl2, in PBS.

Histology

After incubation with X-gal, the tissue was fixed in 10% neutral buffered formalin, embedded in paraffin and sectioned at a thickness of 5-10 [mu]m. Sections were counterstained with nuclear fast red and examined by light microscopy.

ACKNOWLEDGEMENTS

We thank Nicholas Muzyczka for the AAV.CMV lacZ plasmid. This work was supported by the Medical Research Council. M.B.R is supported by Deutsche Forschungsgemeinschaft grant Re1121/1-1 and A.J.T. by the Wellcome Trust.

REFERENCES

1 Bird, A.C. (1995) Retinal photoreceptor dystrophies. Am. J. Ophthalmol. 119, 543-562. MEDLINE Abstract

2 Dryja, T.P., Finn, J.T., Peng, Y.-W., McGee, T.L., Berson, E.L. and Yau, K.W. (1995) Mutations in the gene encoding the [alpha] subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proc. Natl Acad. Sci. USA 92, 10177-10181. MEDLINE Abstract

3 Bascom, R.A., Liu, L., Heckenlively, J.R., Stone, E.M. and McInnes, R.R. (1995) Mutation analysis of the ROM1 gene in retinitis pigmentosa. Hum. Mol. Genet. 4, 1895-1902. MEDLINE Abstract

4 McLaughlin, M.E., Sandberg, M.A., Berson, E.L. and Dryja, T.P. (1993) Recessive mutations in the gene encoding the [beta]-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nature Genet. 4, 130-134. MEDLINE Abstract

5 Farrar, G.J., Kenna, P., Jordan, S.A., Kumar-Singh, R., Humphries, M.M., Sharp, E.M., Shiels, D.M. and Humphries, P. (1991) A three base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature 354, 478-480. MEDLINE Abstract

6 Dryja, T.P., McGee, T.L., Reichel, E., Hahn, L.B., Cowley, G.S., Yandell, D.W., Sandberg, M.A. and Berson, E.L. (1990) A point mutation of rhodopsin gene in one form of retinitis pigmentosa. Nature 343, 364-366. MEDLINE Abstract

7 Mullen, R.J. and LaVail, M.M. (1976) Inherited retinal dystrophy: primary defect in pigment epithelium determined with experimental rat chimeras. Science 192, 799-801. MEDLINE Abstract

8 Jomary, C., Piper, T.A., Dickson, G., Couture, L.A., Smith, A.E., Neal, M.J. and Jones, S.E. (1994) Adeno-virus mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett. 347, 117-122. MEDLINE Abstract

9 Bennett, J., Wilson, J., Sun, D., Forbes, B. and Maguire, A. (1994) Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci. 35, 2535-2542. MEDLINE Abstract

10 Li, T., Adamian, M., Roof, D.J., Berson, E.L., Dryja, T.P., Roessler, B.J. and Davidson, B.L. (1994) In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 35, 2543-2549. MEDLINE Abstract

11 Mashhour, B., Couton, D., Perricaudet, M. and Briand, P. (1994) In vivo adenovirus mediated gene transfer into ocular tissues. Gene Therapy 1, 112-126.

12 Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Pfaff, D.W., O'Malley, K.L. and During, M.J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-153. MEDLINE Abstract

13 Thrasher, A.J., de Alwis, M., Casimir, C.M., Kinnon, C., Page, K., Lebkowski, J., Segal, A.W. and Levinsky, R.J. (1995) Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transfer. Blood 86, 761-765. MEDLINE Abstract


*To whom correspondence should be addressed


This page is maintained by OUP admin. Last updated Thu Oct 31 15:23:49 GMT 1996. Part of the OUP Journals World Wide Web service.Copyright Oxford University Press, 1996


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
M. Allocca, C. Mussolino, M. Garcia-Hoyos, D. Sanges, C. Iodice, M. Petrillo, L. H. Vandenberghe, J. M. Wilson, V. Marigo, E. M. Surace, et al.
Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors
J. Virol., October 15, 2007; 81(20): 11372 - 11380.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. C. Khani, B. S. Pawlyk, O. V. Bulgakov, E. Kasperek, J. E. Young, M. Adamian, X. Sun, A. J. Smith, R. R. Ali, and T. Li
AAV-Mediated Expression Targeting of Rod and Cone Photoreceptors with a Human Rhodopsin Kinase Promoter
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 3954 - 3961.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. S. Pawlyk, A. J. Smith, P. K. Buch, M. Adamian, D.-H. Hong, M. A. Sandberg, R. R. Ali, and T. Li
Gene Replacement Therapy Rescues Photoreceptor Degeneration in a Murine Model of Leber Congenital Amaurosis Lacking RPGRIP
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3039 - 3045.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. M. Gonzalez-Santos, H. Cao, A. Wang, D. R. Koehler, B. Martin, R. Navab, and J. Hu
A complementation method for functional analysis of mammalian genes
Nucleic Acids Res., June 8, 2005; 33(10): e94 - e94.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
G. Le Meur, M. Weber, Y. Pereon, A. Mendes-Madeira, D. Nivard, J.-Y. Deschamps, P. Moullier, and F. Rolling
Postsurgical Assessment and Long-term Safety of Recombinant Adeno-Associated Virus-Mediated Gene Transfer Into the Retinas of Dogs and Primates
Arch Ophthalmol, April 1, 2005; 123(4): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. M. Surace, A. Auricchio, S. J. Reich, T. Rex, E. Glover, S. Pineles, W. Tang, E. O'Connor, A. Lyubarsky, A. Savchenko, et al.
Delivery of Adeno-Associated Virus Vectors to the Fetal Retina: Impact of Viral Capsid Proteins on Retinal Neuronal Progenitor Transduction
J. Virol., July 15, 2003; 77(14): 7957 - 7963.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Davidoff, C. Y. C. Ng, J. Zhou, Y. Spence, and A. C. Nathwani
Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway
Blood, July 15, 2003; 102(2): 480 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. D. Smith, R. F. Collaco, and J. P. Trempe
Enhancement of Recombinant Adeno-Associated Virus Type 2-Mediated Transgene Expression in a Lung Epithelial Cell Line by Inhibition of the Epidermal Growth Factor Receptor
J. Virol., June 1, 2003; 77(11): 6394 - 6404.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W.-C. Wu, C.-C. Lai, S.-L. Chen, X. Xiao, T.-L. Chen, R. J.-F. Tsai, S.-W. Kuo, and Y.-P. Tsao
Gene Therapy for Detached Retina by Adeno-Associated Virus Vector Expressing Glial Cell Line-Derived Neurotrophic Factor
Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3480 - 3488.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C.-C. Lai, W.-C. Wu, S.-L. Chen, X. Xiao, T.-C. Tsai, S.-J. Huan, T.-L. Chen, R. J.-F. Tsai, and Y.-P. Tsao
Suppression of Choroidal Neovascularization by Adeno-associated Virus Vector Expressing Angiostatin
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2401 - 2407.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Yvert, K. S. Lindenberg, S. Picaud, G. B. Landwehrmeyer, J.-A. Sahel, and J.-L. Mandel
Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice
Hum. Mol. Genet., October 1, 2000; 9(17): 2491 - 2506.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sanlioglu, P. K. Benson, J. Yang, E. M. Atkinson, T. Reynolds, and J. F. Engelhardt
Endocytosis and Nuclear Trafficking of Adeno-Associated Virus Type 2 Are Controlled by Rac1 and Phosphatidylinositol-3 Kinase Activation
J. Virol., October 1, 2000; 74(19): 9184 - 9196.
[Abstract] [Full Text]


Home page
IOVSHome page
B. Spencer, S. Agarwala, M. Miskulin, M. Smith, and C. R. Brandt
Herpes Simplex Virus-Mediated Gene Delivery to the Rodent Visual System
Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1392 - 1401.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J. Yang, W. Zhou, Y. Zhang, T. Zidon, T. Ritchie, and J. F. Engelhardt
Concatamerization of Adeno-Associated Virus Circular Genomes Occurs through Intermolecular Recombination
J. Virol., November 1, 1999; 73(11): 9468 - 9477.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. Guy, X. Qi, H. Wang, and W. W. Hauswirth
Adenoviral Gene Therapy With Catalase Suppresses Experimental Optic Neuritis
Arch Ophthalmol, November 1, 1999; 117(11): 1533 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Bennett, A. M. Maguire, A. V. Cideciyan, M. Schnell, E. Glover, V. Anand, T. S. Aleman, N. Chirmule, A. R. Gupta, Y. Huang, et al.
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina
PNAS, August 17, 1999; 96(17): 9920 - 9925.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. Guy, X. Qi, N. Muzyczka, and W. W. Hauswirth
Reporter Expression Persists 1 Year After Adeno-Associated Virus-Mediated Gene Transfer to the Optic Nerve
Arch Ophthalmol, July 1, 1999; 117(7): 929 - 937.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Romano, C. Pacilio, and A. Giordano
Gene Transfer Technology in Therapy: Current Applications and Future Goals
Stem Cells, July 1, 1999; 17(4): 191 - 202.
[Abstract] [Full Text]


Home page
The OncologistHome page
G. Romano, C. Pacilio, and A. Giordano
Gene Transfer Technology in Therapy: Current Applications and Future Goals
Oncologist, August 1, 1998; 3(4): 225 - 236.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Di Polo, L. J. Aigner, R. J. Dunn, G. M. Bray, and A. J. Aguayo
Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells
PNAS, March 31, 1998; 95(7): 3978 - 3983.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Miyoshi, M. Takahashi, F. H. Gage, and I. M. Verma
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
PNAS, September 16, 1997; 94(19): 10319 - 10323.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
R R ALI, M B REICHEL, D M HUNT, and S S BHATTACHARYA
Gene therapy for inherited retinal degeneration
Br. J. Ophthalmol., September 1, 1997; 81(9): 795 - 801.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A. F WRIGHT
Gene therapy for the eye
Br. J. Ophthalmol., August 1, 1997; 81(8): 620 - 622.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. G. Flannery, S. Zolotukhin, M. I. Vaquero, M. M. LaVail, N. Muzyczka, and W. W. Hauswirth
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
PNAS, June 24, 1997; 94(13): 6916 - 6921.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. D. Kessler, G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
PNAS, November 26, 1996; 93(24): 14082 - 14087.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (127)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ali, R. R.
Right arrow Articles by Bhattacharya, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ali, R. R.
Right arrow Articles by Bhattacharya, S. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?